Rosetta Therapeutics
Pioneering the future of pharmaceuticals with breakthrough molecules and efficient assays, reducing costs and advancing cures for human diseases.
Pioneering the future of pharmaceuticals with breakthrough molecules and efficient assays, reducing costs and advancing cures for human diseases.
Rosetta Therapeutics is a promising pharmaceutical startup on the cutting edge of drug discovery. The company's vision is encapsulated in their slogan: "Pioneering the future of pharmaceuticals with breakthrough molecules and efficient assays, reducing costs and advancing cures for human diseases." Founded in 2018, Rosetta Therapeutics operates in the Biotechnology and Health Care industries. The company recently secured a grant investment on 12 November 2020 from Genome Canada, serving as a strong endorsement of their potential. Through their innovative approach that centers around new validated molecules and high-throughput assays, Rosetta Therapeutics aims to mitigate risk and reduce costs for pharmaceutical companies, all while advancing potential cures for human diseases. This recent investment will likely propel Rosetta Therapeutics closer to achieving their groundbreaking goals.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | Unknown | 1 |
|
12 Nov 2020 |
| Pre Seed Round | Unknown | 1 |
|
01 Jan 2017 |
No recent news or press coverage available for Rosetta Therapeutics.
We care about your data, and we'd love to use cookies make your experience better.